Rutherford R A, Smith A, Waibel R, Schubiger P A
Division of Radiopharmacy, Paul Scherrer Institute, Villigen, Switzerland.
Int J Cancer. 1997 Jul 29;72(3):522-9. doi: 10.1002/(sici)1097-0215(19970729)72:3<522::aid-ijc23>3.0.co;2-c.
The basic amino acid L-lysine was administered to mice in an attempt to circumvent unwanted renal accumulation of 67Cu-labelled F(ab')2 fragments derived from the anti-NCAM IgG1, SEN7 and anti-CEA IgG1 monoclonal antibody (MAb)35. In control experiments, significant renal uptake of both 67Cu-labelled F(ab')2 fragments was observed, radiolabel being primarily localised to proximal tubules in the renal cortex. Following optimised L-lysine dosing protocols, renal uptake of 67Cu-MAb35 F(ab')2 was inhibited by up to 42%. Surprisingly, little inhibition (< 10%) of 67Cu-SEN7 F(ab')2 uptake was observed. Experiments to investigate this differential inhibition indicated that inhibition of MAb35 F(ab')2 uptake was relatively short-lived (approx. 6 hr), whilst no apparent differences were found in blood clearance rates between either 67Cu-F(ab')2 fragment. L-lysine administration caused a significant diuresis with high levels of intact 67Cu-labelled SEN7 and MAb35 F(ab')2 appearing in the urine, possibly due to blockade of renal uptake and lysine-induced increases in glomerular membrane permeability. Iso-electric focusing studies failed to identify any charge differences between the 67Cu-labelled F(ab')2 fragments, although a cathodal migration of all 67Cu-labelled samples, presumably due to the net positive charge conferred by addition of 67Cu2+ ions, was observed. Our results demonstrate that in addition to net charge, other unidentified characteristics may influence renal accumulation of radiometal-labelled F(ab')2 fragments and their inhibition by L-lysine.
给予小鼠碱性氨基酸L-赖氨酸,试图避免67Cu标记的源自抗NCAM IgG1、SEN7和抗CEA IgG1单克隆抗体(MAb)35的F(ab')2片段在肾脏中不必要的蓄积。在对照实验中,观察到两种67Cu标记的F(ab')2片段均有明显的肾脏摄取,放射性标记主要定位于肾皮质的近端小管。按照优化的L-赖氨酸给药方案,67Cu-MAb35 F(ab')2的肾脏摄取被抑制高达42%。令人惊讶的是,观察到67Cu-SEN7 F(ab')2摄取的抑制作用很小(<10%)。研究这种差异抑制作用的实验表明,MAb35 F(ab')2摄取的抑制作用相对短暂(约6小时),而两种67Cu-F(ab')2片段的血液清除率没有明显差异。给予L-赖氨酸导致显著的利尿作用,尿液中出现高水平的完整67Cu标记的SEN7和MAb35 F(ab')2,这可能是由于肾脏摄取受阻以及赖氨酸诱导的肾小球膜通透性增加所致。等电聚焦研究未能确定67Cu标记的F(ab')2片段之间的任何电荷差异,尽管观察到所有67Cu标记样品均向阴极迁移,推测这是由于添加67Cu2+离子赋予的净正电荷所致。我们的结果表明,除了净电荷外,其他未确定的特性可能会影响放射性金属标记的F(ab')2片段在肾脏中的蓄积及其被L-赖氨酸的抑制作用。